Sign inJoin waitlistJoin the waitlist

Hannah Choe

Physician · Ohio State University College of Medicine

Credentials: · · · · · · ·

History

Ohio State University College of Medicine
Present

Hematology and Medical Oncology
2015–2018
Internal Medicine
2012–2015
Indiana University School of Medicine
2007–2011

Research

National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide
Journal of Clinical Oncology · 2021 · 188 citations
American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults
Blood Advances · 2020 · 157 citations
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
New England Journal of Medicine · 2024 · 130 citations

Carrie Kitko
22 papers
James Ferrara
22 papers
John Levine
22 papers
Zachariah DeFilipp
21 papers
Aaron Etra
20 papers
Elizabeth Hexner
20 papers
William Hogan
20 papers
Ryotaro Nakamura
19 papers
Sumithira Vasu
19 papers
Muna Qayed
18 papers
Ran Reshef
17 papers
NS
Nikolaos Spyrou
15 papers · 14 as a resident

Grants

Targeting Epigenetic Regulation via Bromodomain and Extraterminal (BET) Domain Inhibition for Treatment of GVHD
National Cancer Institute · R01
Contact PI · $2M · Ohio State University
2021–2027

Clinical trials

Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
Principal investigator · Recruiting · Phase 2
Hannah Choe, MD
2026–2027
Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD
Principal investigator · Terminated · Phase 1, Phase 2
Hannah Choe, MD
2022–2023
High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant
Principal investigator · Completed
Ohio State University Comprehensive Cancer Center
2020–2025
Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease
Principal investigator · Completed
Ohio State University Comprehensive Cancer Center
2012–2024